Ranking · Winter 2025 · B2B · Engineering, Product and Design

Delineate

Agents for Accelerated Clinical Trial Design

9.4%

odds of being acquired in the next two years

1.4× the average (6.8%)

#592 of 4,339 active YC companies · top 15%

Team of 20 · Boston, MA, USA; Remote

Raises the odds

↑ 1.5–3 years since YC

↑ industry: B2B

↑ tag: SaaS

↑ based in Fully Remote

Lowers the odds

↓ tag: AI

↓ “design” in its one-liner

↓ tag: Biotech

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Delineate's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

delineate.pro YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub